- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05490615
The Virtual Mindfulness Study
Virtual Mindfulness for Autistic Adults: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
It is well recognized that autistic individuals experience high rates of mental health issues, but that needed mental health services are often inaccessible. There is some evidence to suggest that mindfulness-based therapies may help to reduce some of these challenges for autistic adults. While in person interventions may be helpful, there are also benefits to participating in virtually based interventions, particularly during the pandemic. Virtual groups have the added benefit of not requiring travel for people who have difficulties with travel because of anxiety or financial constraints. For some autistic individuals, virtual engagement can be preferred over in person interactions because of the flexibility that virtual interactions allow (camera on or off, communicating with text or speaking, being able to attend from home in a familiar and comfortable space).
In a prior CAMH led study, the investigators demonstrated that autism-informed adaptations to a standard mindfulness-based virtually delivered group intervention led to self-reported improvements in mindfulness, self-compassion, and distress, with changes maintained at three months follow-up. This prior study lacked a control group, however so it is not known whether the positive impacts reported were specific to the mindfulness-based intervention itself or to other factors. Building on this previous work, there is a need to study whether improvements are also evident when compared to individuals who do not take part in the intervention.
The purpose of this study is to test the effectiveness of a virtual group mindfulness intervention for autistic adults on their mental health and well-being, compared to a group who has not received the virtual group intervention. Specifically, the investigators will compare change across multiple indicators of mental health and well-being for participants, post-intervention, and at 15 weeks follow-up, to participants in a waitlist control group who have not yet received the intervention.
Study Design: Randomized controlled trial with waitlist control.
Hypotheses We expect that participants in the mindfulness-based intervention group will report improvements in self-reported distress (primary outcome), mindfulness, self-compassion, and sense of autistic belonging (secondary outcomes), relative to the waitlist control group, which will be maintained at 15 weeks follow-up.
Survey Evaluation: All participants will provide pre, post and follow-up survey data related to either a 6-week virtual mindfulness course or waitlist. Participants will fill out survey measures evaluating the impact of either the intervention or waitlist on distress levels, self-compassion, mindfulness, and connections from baseline (Time 1) to week 7 (Time 2) and week 15 (Time 3). In addition, the waitlist control group (Group B) will be offered virtual mindfulness intervention from week 16 to week 21 and will be asked to complete 2 additional set of questionnaires at week 22 and at week 30, thus providing data pre and post with follow-up related to the mindfulness intervention.
Study Setting: This study will be delivered virtually but will be offered through CAMH, Toronto.
Target Population We aim to recruit in total 80 autistic adults from across Canada.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yona Lunsky, PhD
- Phone Number: 4165358501
- Email: yona.lunsky@camh.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5V 2B4
- CAMH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 18 years and older;
- Autistic
- Proficient in English;
- Able to independently complete survey questionnaires;
- Able to independently participate in an online based group;
- Access to internet and computer/tablet
Exclusion Criteria:
- Presence of intellectual disability;
- Unable to comprehend English or speak or write in English;
- No access to internet and computer/tablet.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindfulness Intervention (Group-A)
Total length of study for participants in Group-A:15 Week Six weekly sessions (each 60 minutes in length) of group based virtual mindfulness instruction, co-led by a mindfulness teacher and two autistic adults, following a workbook designed for autistic adults. In between sessions, participants are encouraged to complete homework and keep a record of when they practice formal and informal mindfulness practices. In addition, participants are provided with a link to autism informed mental health resources (https://www.yorku.ca/health/lab/ddmh/am-help/) |
Investigators have previously developed and tested a virtual mindfulness program.
Six 1-hour weekly group sessions will be led on WebEx.
Focus will be on skill building through the teaching of formal and informal mindfulness practices.
The intervention, based on the MBSR curriculum, has been modified to make it more accessible for autistic adults.
The curriculum developed for this program was designed with autistic advisors guiding the team on the length of meditations, the language used when giving instructions, and the range of techniques that would be most helpful for autistic adults.
Each activity is presented as optional, recognizing that some people may find certain silent sensory experiences too distressing.
Autistic advisors will participate in sessions as co-facilitators and multiple communication options will be available to group participants (text and audio, camera on or off).
|
No Intervention: Waitlist Control (Group-B)
Total length of study for participants in Group-B: 30 Week A waitlist control group is an ethical alternative to no-treatment control groups when studying psychological and behavioral interventions. This group will have access to intervention at the end of the study as well. All waitlist participants are provided with a link to autism informed mental health resources (https://www.yorku.ca/health/lab/ddmh/am-help/) |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Psychological distress: measured using the Depression and Anxiety Stress Scale (DASS-21)
Time Frame: Baseline or enrolment (Group-A and Group B)
|
To assess psychological distress, including a 7-item depression subscale, a 7 -item anxiety subscale, and a 7-item stress subscale, each on a 4-point Likert scale, with higher scores indicating higher levels of distress.
Total scores for each subscale range from 0 to 42 (summed numbers in each subscale multiplied by 2).
|
Baseline or enrolment (Group-A and Group B)
|
Psychological distress: measured using the Depression and Anxiety Stress Scale (DASS-21)
Time Frame: 7 Weeks (Group-A and Group B)
|
To assess psychological distress, including a 7-item depression subscale, a 7 -item anxiety subscale, and a 7-item stress subscale, each on a 4-point Likert scale, with higher scores indicating higher levels of distress.
Total scores for each subscale range from 0 to 42 (summed numbers in each subscale multiplied by 2).
|
7 Weeks (Group-A and Group B)
|
Psychological distress: measured using the Depression and Anxiety Stress Scale (DASS-21)
Time Frame: 15 Weeks (Group-A and Group B)
|
To assess psychological distress, including a 7-item depression subscale, a 7 -item anxiety subscale, and a 7-item stress subscale, each on a 4-point Likert scale, with higher scores indicating higher levels of distress.
Total scores for each subscale range from 0 to 42 (summed numbers in each subscale multiplied by 2).
|
15 Weeks (Group-A and Group B)
|
Psychological distress: measured using the Depression and Anxiety Stress Scale (DASS-21)
Time Frame: 22 Weeks (Group-B)
|
To assess psychological distress, including a 7-item depression subscale, a 7 -item anxiety subscale, and a 7-item stress subscale, each on a 4-point Likert scale, with higher scores indicating higher levels of distress.
Total scores for each subscale range from 0 to 42 (summed numbers in each subscale multiplied by 2).
|
22 Weeks (Group-B)
|
Psychological distress: measured using the Depression and Anxiety Stress Scale (DASS-21)
Time Frame: 30 Weeks (Group-B)
|
To assess psychological distress, including a 7-item depression subscale, a 7 -item anxiety subscale, and a 7-item stress subscale, each on a 4-point Likert scale, with higher scores indicating higher levels of distress.
Total scores for each subscale range from 0 to 42 (summed numbers in each suscale multiplied by 2).
|
30 Weeks (Group-B)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Autistic Participant Self Compassion - measured using Self Compassion Scale-Short Form (SCS-SF)
Time Frame: Baseline/enrolment (Group-A and Group B)
|
12-item measure that assesses the ability to demonstrate care and kindness toward oneself, and acceptance of one's own imperfections.
Self-compassion is often a focus of mindfulness-based interventions because of the interrelatedness with state mindfulness.
Responses will be given using a 5-point Likert scale that ranged from 1 ("Almost never") to 5 ("Almost always"), yielding a total score between 12 and 60, with higher scores indicating greater self-compassion.
|
Baseline/enrolment (Group-A and Group B)
|
Autistic Participant Self Compassion - measured using Self Compassion Scale-Short Form (SCS-SF)
Time Frame: 7 week (Group-A and Group B)
|
12-item measure that assesses the ability to demonstrate care and kindness toward oneself, and acceptance of one's own imperfections.
Self-compassion is often a focus of mindfulness-based interventions because of the interrelatedness with state mindfulness.
Responses will be given using a 5-point Likert scale that ranged from 1 ("Almost never") to 5 ("Almost always"), yielding a total score between 12 and 60, with higher scores indicating greater self-compassion.
|
7 week (Group-A and Group B)
|
Autistic Participant Self Compassion - measured using Self Compassion Scale-Short Form (SCS-SF)
Time Frame: 15 Week (Group-A and Group B)
|
12-item measure that assesses the ability to demonstrate care and kindness toward oneself, and acceptance of one's own imperfections.
Self-compassion is often a focus of mindfulness-based interventions because of the interrelatedness with state mindfulness.
Responses will be given using a 5-point Likert scale that ranged from 1 ("Almost never") to 5 ("Almost always"), yielding a total score between 12 and 60, with higher scores indicating greater self-compassion.
|
15 Week (Group-A and Group B)
|
Autistic Participant Self Compassion - measured using Self Compassion Scale-Short Form (SCS-SF)
Time Frame: 22 Week (Group B)
|
12-item measure that assesses the ability to demonstrate care and kindness toward oneself, and acceptance of one's own imperfections.
Self-compassion is often a focus of mindfulness-based interventions because of the interrelatedness with state mindfulness.
Responses will be given using a 5-point Likert scale that ranged from 1 ("Almost never") to 5 ("Almost always"), yielding a total score between 12 and 60, with higher scores indicating greater self-compassion.
|
22 Week (Group B)
|
Autistic Participant Self Compassion - measured using Self Compassion Scale-Short Form (SCS-SF)
Time Frame: 30 Week (Group B)
|
12-item measure that assesses the ability to demonstrate care and kindness toward oneself, and acceptance of one's own imperfections.
Self-compassion is often a focus of mindfulness-based interventions because of the interrelatedness with state mindfulness.
Responses will be given using a 5-point Likert scale that ranged from 1 ("Almost never") to 5 ("Almost always"), yielding a total score between 12 and 60, with higher scores indicating greater self-compassion.
|
30 Week (Group B)
|
Autistic Community connectedness (ACC) - measured using Autistic Community Connectedness Measure (ACC)
Time Frame: Baseline/enrolment (Group-A and Group B)
|
ACC will be used to measure how connected to the autistic community each participant felt.
It comprises of ten statements and is rated on a 6-point Likert scale ranging from 1('strongly disagree') to 6, ('strongly agree').
Total scores range from 10 to 60, with higher scores reflecting greater autistic community connectedness.
|
Baseline/enrolment (Group-A and Group B)
|
Autistic Community connectedness (ACC) - measured using Autistic Community Connectedness Measure (ACC)
Time Frame: 7 week (Group-A and Group B)
|
ACC will be used to measure how connected to the autistic community each participant felt.
It comprises of ten statements and is rated on a 6-point Likert scale ranging from 1('strongly disagree') to 6, ('strongly agree').
Total scores range from 10 to 60, with higher scores reflecting greater autistic community connectedness.
|
7 week (Group-A and Group B)
|
Autistic Community connectedness (ACC) - measured using Autistic Community Connectedness Measure (ACC)
Time Frame: 15 Week (Group-A and Group B)
|
ACC will be used to measure how connected to the autistic community each participant felt.
It comprises of ten statements and is rated on a 6-point Likert scale ranging from 1('strongly disagree') to 6, ('strongly agree').
Total scores range from 10 to 60, with higher scores reflecting greater autistic community connectedness.
|
15 Week (Group-A and Group B)
|
Autistic Community connectedness (ACC) - measured using Autistic Community Connectedness Measure (ACC)
Time Frame: 22 Week (Group B)
|
ACC will be used to measure how connected to the autistic community each participant felt.
It comprises of ten statements and is rated on a 6-point Likert scale ranging from 1('strongly disagree') to 6, ('strongly agree').
Total scores range from 10 to 60, with higher scores reflecting greater autistic community connectedness.
|
22 Week (Group B)
|
Autistic Community connectedness (ACC) - measured using Autistic Community Connectedness Measure (ACC)
Time Frame: 30 Week (Group B)
|
ACC will be used to measure how connected to the autistic community each participant felt.
It comprises of ten statements and is rated on a 6-point Likert scale ranging from 1('strongly disagree') to 6, ('strongly agree').
Total scores range from 10 to 60, with higher scores reflecting greater autistic community connectedness.
|
30 Week (Group B)
|
Autistic Participant Satisfaction-measured using Intervention Satisfaction Scale (ISS)
Time Frame: 7 Week (Group-A)
|
At the end of virtual mindfulness session.
Participants will be asked open-ended questions asking about what they liked best and least about the group, what the biggest challenges they had to attending group meetings, what would make participation easier, and how they would change the group for future participants via an online survey will be distributed at the end of the course with the post-evaluation measures.
Participants will be asked to rate some items, how generally true each item was for them using a 5-point scale ranging from 1 ("Never or very rarely true") to 5 ("Very often or always true"), with higher total scores suggesting greater mindfulness (total score range from 0 to 100)
|
7 Week (Group-A)
|
Autistic Participant Satisfaction-measured using Intervention Satisfaction Scale (ISS)
Time Frame: 22 Week (Group B)
|
At the end of virtual mindfulness session. Participants will be asked open-ended questions asking about what they liked best and least about the group, what the biggest challenges they had to attending group meetings, what would make participation easier, and how they would change the group for future participants via an online survey will be distributed at the end of the course with the post-evaluation measures. Participants will be asked to rate some items, how generally true each item was for them using a 5-point scale ranging from 1 ("Never or very rarely true") to 5 ("Very often or always true"), with higher total scores suggesting greater mindfulness (total score range from 0 to 100). |
22 Week (Group B)
|
Autistic Participant reactivity, observing, acting aware, describing, and non-judgment- measured using Five-Facet Mindfulness Questionnaire- Short Form (FFMQ-SF)
Time Frame: Baseline/ enrolment (Group-A and Group B)
|
FFMQ-SF will be used to assess five components of mindfulness: observing one's experiences, describing one's experiences, acting with awareness, accepting inner experiences in a nonjudgmental way, and accepting inner experiences without reacting.
Participants will be asked to rate how generally true each item was for them using a 5-point scale ranging from 1 ("Never or very rarely true") to 5 ("Very often or always true"), with higher total scores suggesting greater mindfulness (total score range from 24 to 120).
|
Baseline/ enrolment (Group-A and Group B)
|
Autistic Participant reactivity, observing, acting aware, describing, and non-judgment- measured using Five-Facet Mindfulness Questionnaire- Short Form (FFMQ-SF)
Time Frame: 7 Week (Group-A and Group B)
|
FFMQ-SF will be used to assess five components of mindfulness: observing one's experiences, describing one's experiences, acting with awareness, accepting inner experiences in a nonjudgmental way, and accepting inner experiences without reacting.
Participants will be asked to rate how generally true each item was for them using a 5-point scale ranging from 1 ("Never or very rarely true") to 5 ("Very often or always true"), with higher total scores suggesting greater mindfulness (total score range from 24 to 120).
|
7 Week (Group-A and Group B)
|
Autistic Participant reactivity, observing, acting aware, describing, and non-judgment- measured using Five-Facet Mindfulness Questionnaire- Short Form (FFMQ-SF)
Time Frame: 15 Week (Group-A and Group B)
|
FFMQ-SF will be used to assess five components of mindfulness: observing one's experiences, describing one's experiences, acting with awareness, accepting inner experiences in a nonjudgmental way, and accepting inner experiences without reacting.
Participants will be asked to rate how generally true each item was for them using a 5-point scale ranging from 1 ("Never or very rarely true") to 5 ("Very often or always true"), with higher total scores suggesting greater mindfulness (total score range from 24 to 120).
|
15 Week (Group-A and Group B)
|
Autistic Participant reactivity, observing, acting aware, describing, and non-judgment- measured using Five-Facet Mindfulness Questionnaire- Short Form (FFMQ-SF)
Time Frame: 22 Week (Group B)
|
FFMQ-SF will be used to assess five components of mindfulness: observing one's experiences, describing one's experiences, acting with awareness, accepting inner experiences in a nonjudgmental way, and accepting inner experiences without reacting.
Participants will be asked to rate how generally true each item was for them using a 5-point scale ranging from 1 ("Never or very rarely true") to 5 ("Very often or always true"), with higher total scores suggesting greater mindfulness (total score range from 24 to 120).
|
22 Week (Group B)
|
Autistic Participant reactivity, observing, acting aware, describing, and non-judgment- measured using Five-Facet Mindfulness Questionnaire- Short Form (FFMQ-SF)
Time Frame: 30 Week (Group B)
|
FFMQ-SF will be used to assess five components of mindfulness: observing one's experiences, describing one's experiences, acting with awareness, accepting inner experiences in a nonjudgmental way, and accepting inner experiences without reacting.
Participants will be asked to rate how generally true each item was for them using a 5-point scale ranging from 1 ("Never or very rarely true") to 5 ("Very often or always true"), with higher total scores suggesting greater mindfulness (total score range from 24 to 120).
|
30 Week (Group B)
|
Autistic Participant Interoception measured using, Interoception Sensory Questionnaire (ISQ-8)
Time Frame: Baseline (Group-A and Group B)
|
ISQ-8 will be used to measure interoception, the ISQ-8 is the first psychometrically validated self-report measure of interoception for autistic adolescents and adults,and is adapted from the ISQ-20.
Items are rated on a 5-point likert scale.
A higher score indicates more difficulty registering or interpreting interoceptive sensations.
|
Baseline (Group-A and Group B)
|
Autistic Participant Interoception measured using, Interoception Sensory Questionnaire (ISQ-8)
Time Frame: 7 Week (Group-A and Group B)
|
ISQ-8 will be used to measure interoception, the ISQ-8 is the first psychometrically validated self-report measure of interoception for autistic adolescents and adults,and is adapted from the ISQ-20.
Items are rated on a 5-point likert scale.
A higher score indicates more difficulty registering or interpreting interoceptive sensations.
|
7 Week (Group-A and Group B)
|
Autistic Participant Interoception measured using, Interoception Sensory Questionnaire (ISQ-8)
Time Frame: 15 Week (Group-A and Group B)
|
ISQ-8 will be used to measure interoception, the ISQ-8 is the first psychometrically validated self-report measure of interoception for autistic adolescents and adults,and is adapted from the ISQ-20.
Items are rated on a 5-point likert scale.
A higher score indicates more difficulty registering or interpreting interoceptive sensations.
|
15 Week (Group-A and Group B)
|
Autistic Participant Interoception measured using, Interoception Sensory Questionnaire (ISQ-8)
Time Frame: 22 Week (Group B)
|
ISQ-8 will be used to measure interoception, the ISQ-8 is the first psychometrically validated self-report measure of interoception for autistic adolescents and adults,and is adapted from the ISQ-20.
Items are rated on a 5-point likert scale.
A higher score indicates more difficulty registering or interpreting interoceptive sensations.
|
22 Week (Group B)
|
Autistic Participant Interoception measured using, Interoception Sensory Questionnaire (ISQ-8)
Time Frame: 30 Week (Group B)
|
ISQ-8 will be used to measure interoception, the ISQ-8 is the first psychometrically validated self-report measure of interoception for autistic adolescents and adults,and is adapted from the ISQ-20.
Items are rated on a 5-point likert scale.
A higher score indicates more difficulty registering or interpreting interoceptive sensations.
|
30 Week (Group B)
|
Autistic participant mental well-being measured using, the Short Warwick-Edinburgh Mental Wellbeing Scale, SWEMWS
Time Frame: Baseline (Group-A and Group B)
|
The Short Warwick-Edinburgh Mental Wellbeing Scale, SWEMWS is a 7-item measure of psychological wellbeing.
Example items include 'I've been feeling relaxed' and 'I've been interested in new things'.
Participants rated items on a 5-point Likert scale ['none of the time' (1) to 'all of the time' (5)].
Scores could range from 14 to 70, and higher scores indicated more positive mental wellbeing.
|
Baseline (Group-A and Group B)
|
Autistic participant mental well-being measured using, the Short Warwick-Edinburgh Mental Wellbeing Scale, SWEMWS
Time Frame: 7 Week (Group-A and Group B)
|
The Short Warwick-Edinburgh Mental Wellbeing Scale, SWEMWS is a 7-item measure of psychological wellbeing.
Example items include 'I've been feeling relaxed' and 'I've been interested in new things'.
Participants rated items on a 5-point Likert scale ['none of the time' (1) to 'all of the time' (5)].
Scores could range from 14 to 70, and higher scores indicated more positive mental wellbeing.
|
7 Week (Group-A and Group B)
|
Autistic participant mental well-being measured using, the Short Warwick-Edinburgh Mental Wellbeing Scale, SWEMWS
Time Frame: 15 Week (Group-A and Group B)
|
The Short Warwick-Edinburgh Mental Wellbeing Scale, SWEMWS is a 7-item measure of psychological wellbeing.
Example items include 'I've been feeling relaxed' and 'I've been interested in new things'.
Participants rated items on a 5-point Likert scale ['none of the time' (1) to 'all of the time' (5)].
Scores could range from 14 to 70, and higher scores indicated more positive mental wellbeing.
|
15 Week (Group-A and Group B)
|
Autistic participant mental well-being measured using, the Short Warwick-Edinburgh Mental Wellbeing Scale, SWEMWS
Time Frame: 22 Week (Group B)
|
The Short Warwick-Edinburgh Mental Wellbeing Scale, SWEMWS is a 7-item measure of psychological wellbeing.
Example items include 'I've been feeling relaxed' and 'I've been interested in new things'.
Participants rated items on a 5-point Likert scale ['none of the time' (1) to 'all of the time' (5)].
Scores could range from 14 to 70, and higher scores indicated more positive mental wellbeing.
|
22 Week (Group B)
|
Autistic participant mental well-being measured using, the Short Warwick-Edinburgh Mental Wellbeing Scale, SWEMWS
Time Frame: 30 Week (Group B)
|
The Short Warwick-Edinburgh Mental Wellbeing Scale, SWEMWS is a 7-item measure of psychological wellbeing.
Example items include 'I've been feeling relaxed' and 'I've been interested in new things'.
Participants rated items on a 5-point Likert scale ['none of the time' (1) to 'all of the time' (5)].
Scores could range from 14 to 70, and higher scores indicated more positive mental wellbeing.
|
30 Week (Group B)
|
Follow-up Satisfaction Form
Time Frame: End of the Study
|
At the end of the study participants will be asked 8 likert scale close ended questions and 10 open ended questions about what they liked best about the research study what were the biggest challenges they had, what would make participation easier, and what they would change for future participants via online survey at the end of the study.
|
End of the Study
|
Collaborators and Investigators
Investigators
- Principal Investigator: Yona Lunsky, PhD, CAMH
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism
-
EarliTec Diagnostics, IncMarcus Autism CenterRecruitingAutism Spectrum Disorder | Developmental Delay | Autism | Autism, Early Infantile | Autism, InfantileUnited States
-
IRIS Media IncCompletedAutism DisorderUnited States
-
University of California, San FranciscoWithdrawn
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
Forest LaboratoriesMerz Pharmaceuticals GmbHCompletedAutism | Pediatric AutismUnited States
-
University of Medicine and Dentistry of New JerseyNational Alliance for Autism ResearchCompleted
-
The Hong Kong Polytechnic UniversityRecruitingAutism Spectrum Disorder | High-functioning AutismHong Kong
-
Emory UniversityNational Institute of Mental Health (NIMH)Terminated
-
University of California, Los AngelesNational Institute of Mental Health (NIMH); Florida State University; Autism...CompletedAutism Spectrum DisordersUnited States
-
University Hospital, MontpellierCaisse Nationale de Solidarité pour l'AutonomieActive, not recruitingAutism Spectrum DisordersFrance
Clinical Trials on Virtual Mindfulness
-
Chinese University of Hong KongNot yet recruitingStress | Virtual Reality | Mindfulness | StudentChina
-
University of PennsylvaniaSuspendedPrenatal StressUnited States
-
University of the Sciences in PhiladelphiaCompleted
-
Stanford UniversitySuspendedChronic Pain | Acute PainUnited States
-
Stanford UniversityUnknownAbdominal Pain | Anxiety | Eating Disorder
-
Universidad Miguel Hernandez de ElcheUniversidad Complutense de MadridRecruitingBurnout, Student | Mental Health Wellness | University Students | Occupational BalanceSpain
-
University of North Carolina, Chapel HillNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)RecruitingAnterior Cruciate Ligament InjuryUnited States
-
Nanjing University of Traditional Chinese MedicineRecruiting
-
Universidad San Francisco de QuitoMclean HospitalRecruitingSymptoms of Depression and AnxietyEcuador
-
Istituto per la Ricerca e l'Innovazione BiomedicaCompletedAutism Spectrum Disorder | ParentsItaly